A new report from DoubleVerify reveals that 97% of marketers intend to use AI in media planning, buying, and optimization in 2026. However, AI adoption is uneven across specific advertising tasks like media briefs, campaign activation, bidding, and mid-flight optimization. Despite this, AI-powered bidding shows strong performance improvements, with 98% of users reporting better results. Marketers prioritize accuracy, data privacy, and ROI when choosing AI solutions, signaling growing trust and reliance on AI to enhance ad campaign effectiveness.
The story on marketers' plans to use AI provides context for the Technology sector's recent performance on Pluang. As of Oct 29, 2026 19:13 WIB, out of 150 priced Technology-sector US stocks, 21 rose and 127 fell. Notable movers include ServiceNow Inc (NOW) at USD 122.80 with a 1-day change of -18.20%, Marvell Technology Inc (MRVL) at USD 221.88 down 11.83%, and Cognizant Technology Solutions Corp (CTSH) at USD 59.00 down 11.09%.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
